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The investigation of the crossing of exogenous substances through the blood-brain barrier 
(BBB) is object of intensive research in biomedicine, and one of the main obstacles for 
reliable in vitro evaluations is represented by the difficulties at the base of developing realistic 
models of the barrier, that could resemble as most accurately as possible the in vivo 
environment. Here, for the first time, a 1:1 scale, biomimetic and biohybrid BBB model is 
proposed, developed by taking advantage of an innovative submicrometric-resolution 3D 
printing technique, namely two-photon lithography. Microtubes inspired to the brain 
capillaries were fabricated and used as scaffolds for the co-culturing of endothelial-like 
bEnd.3 and U87 glioblastoma cells. The constructs show the maturation of tight junctions, 
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good performances in terms of hindering dextran diffusion through the barrier with respect to 
the microfluidic system without cells, and a satisfactory trans-endothelial electrical resistance 
(75 ± 2 Ω cm2), which is comparable to that observed in the literature with bEnd.3 monolayer-
based models. Moreover, a mathematical model has been developed, that assisted both the 
design of the 3D microfluidic chip and its characterization. Overall, these results show the 
effective formation of a bioinspired cellular barrier based on microtubes reproducing brain 
microcapillaries to scale. This system will be exploited as a realistic in vitro model for the 
investigation of BBB crossing of nanomaterials and drugs, envisaging therapeutic and 
diagnostic applications for several brain pathologies, including brain cancer. 
 
 
Incidence of central nervous systems (CNS) disorders is still rising despite the significant 
improvement in the understanding of their pathological mechanisms, and many new drugs, 
even if virtually able to treat these disorders, have not yet been clinically investigated because 




The elaboration of reliable in vitro models of the BBB is extremely relevant both for 
investigating the development of neurovascular disorders
[4-6]
 and for performing high-
throughput screening of drug delivery through the BBB, and thus to treat CNS disorders.
[7] 
Furthermore, the possibility to mimic as most faithfully as possible in vitro the structure and 
the functionality of the neurovascular system could allow to rigorously study the BBB 
crossing without the use of in vivo models, thus limiting important ethical concerns.
[8]
 Finally, 
the accessibility of the in vitro models consents to finely tune different microenvironmental 
conditions and to easily quantify the biophysical effects of experimental treatments.
[9-10]
 For 
all these reasons, great efforts have been put forward the development of realistic in vitro 
models of the BBB, from simple two-dimensional (2D) models (for a comprehensive review 
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the reader is referred to Cecchelli et al.
[7]
 and to Wilhelm et al.
[11]
), to 2D microfluidic 
chips,
[12-14]
 up to arriving to more complex biomimetic three-dimensional (3D) systems.
[15-17]
 
Here, we present for the first time a dynamic 3D biohybrid model of the BBB able to 
reproduce at 1:1 scale the capillaries of the neurovascular system. In order to mimic the 
function/structure of the brain microvessels, which are characterized by a size of about 10 µm, 
we exploited an advanced 3D microfabrication technique, namely two-photon lithography 
(TPL). This biohybrid BBB consists of porous tubular structures, each of them scaffolding a 
biological barrier of endothelial cells connected by tight junctions, with the aim of 
recapitulating the typical 3D tubular structure and the micrometric size of the brain 
capillaries. 
The main components of the envisaged BBB physical model had to mimic brain 
microcapillaries: we considered tubes having 10 µm average diameter,
[18,19]
 encasing a liquid 




 (assuming a water-like working fluid as 
discussed below, the associated Reynolds number is on the order of 10
-2
). Moreover, on the 
surface of each tube, we assumed a regular pattern of circular orifices (hereafter called pores) 
allowing for mass transport towards the external environment (as functional to the 
investigation of BBB crossing by selected species transported along with the flow in the 
microcapillaries). 
With reference to the schematic in Figure 1a, in order to ice-break chip design we assumed: 
ϕp = 1 µm as pore diameter; the pores to lie on cross-sectional planes uniformly distributed 
along the tube axis with pitch h = 2.5 µm; np = 8 pores uniformly distributed on each 
corresponding cross-section, with subsequent cross-sections being angularly shifted by 
π/np rad to enhance pore density. We considered nt = 50 tubes to be fed in parallel, for two 
practical reasons: not to operate the circuit with exceedingly low inlet flow rates, and to 
enhance detection capabilities thanks to redundancy. 
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We correspondingly defined an inlet and an outlet structure (channels), as well as junction 
structures to reach the main working region comprising the porous tube segments, framed by 
size-matching non-porous tube segments conceived as inflow and outflow guides. A 
corresponding schematic is shown in Figure 1b. The outlet was assumed to reach an external 
discharge region, namely a liquid domain similar to that one external to the tubes yet kept 
separate from the latter by a solid septum. At that design stage we tentatively set H = 800 µm 
as characteristic size for the main working region (essentially to keep fabrication times 
manageable), whereas the length l of the porous tube segments was still to be defined. 
This microfluidic system has been fabricated by exploiting the TPL, a high-resolution 
photolithographic technique which allows for the 3D fabrication of nanostructured 
scaffolds,
[22]
 owing to the phenomenon of the two-photon polymerization of dedicated 
photoresists (Figure 1c). 
In Figure 1d, it is possible to appreciate the geometric model of the whole microfluidic 
system, while a magnification of the porous microcapillaries characterized by a 10 µm 
diameter is shown in Figure 1e. Scanning electron microscopy (SEM) of the obtained 
microfluidic chip and of the porous microtubes are instead respectively reported in Figure 1f 
and Figure 1g. These scans reveal the high reproducibility and accuracy of the TPL approach, 
which allows polymerizing structures faithfully reproducing the 3D model. A high 
magnification SEM image of the pores is shown in Figure 1h, from which we have evaluated 
an average pore diameter of about 1 µm (1.05 ± 0.08 µm): the low standard deviation of this 
measurement quantitatively confirms the high reliability and reproducibility of the TPL 
technique. 
Further details of the structure design and fabrication are reported as Supporting Information 
(Figure S1-S3). Although 1 µm pores were adopted for all the experiments presented in this 
work, we also demonstrated the possibility to finely tune the pore diameter (Supporting 
Information, Figure S4) for the fabrication of different future prototypes. 
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Concerning the model-based design of our system, we adequately substantiated the 
assumption of flows occurring in parallel through numerical simulations (Figures 2a-c). 
Specifically, Figure 2a and 2b are the intensity plots related to the fluid speed; Figure 2b 
shows that the struts locally affect the flow filed, yet in correspondence to the microcapillaries 
inlet section (denoted by abscissa xT1) the flow is uniform. This is further remarked by 
Figure 2c that express the axial velocity profiles obtained through cut-sections immediately 
before and after (distance δ = 0.01 µm) the considered inlet section. The details of the 
numerical simulations are reported in Supporting Information. 
Based on preliminary fabrication tests, we adopted ϕt = 9.5 µm and th = 1 µm for the tube 
inner diameter and thickness, respectively. We then addressed the determination of l based on 
the following arguments. In the absence of pores, one expects the flow to approximately 
conform to the classical Poiseuille flow (at least far enough from the tube end-sections), 
expressed by the following equation:
[23]
 







 ,      (1) 
where Q and p respectively denote flow rate (along the tube) and pressure, µ indicates fluid 
viscosity, and prime hereafter denotes differentiation with respect to the axial space 
coordinate. For the Poiseuille solution the pressure gradient is constant: pressure linearly 
decreases along the tube axial direction due to viscous effects. Considering the pores, 
however, a stronger decrease in pressure can be hypothesized, due to the spillage potentially 
occurring at any pores. Moreover, the higher the (local) pressure is, the higher the spilling 
flow rate should be (for a given pore geometry). Indeed, for the Stokes flow through a 
















 ,     (2) 
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where q and p - pext denote spillage flow rate and pressure difference (internal versus 
external), respectively. The considered fluid-dynamic problem is sketched in Figure 2d and 
Figure 2e. In the latter subfigure, in particular, Poiseuille-like parabolic velocity profiles are 
used to depict the spillage potentially occurring when the pore diameter is sensibly smaller 
than the tube diameter and the pores are enough distant from one another for the 
corresponding spillages to be “mutually independent” (this approximation seemed to be 
reasonable in our case). Consistently, after some characteristic length over which the pressure 
difference is fully dissipated by viscous effects, the spillage is expected to be negligible (here 
we are tacitly assuming that the outlet boundary conditions are such that the flow can evolve 
according to the described dynamics; this is not a limiting assumption as clarified below). We 
decided to estimate the aforementioned characteristic length in order to assign l. Indeed, 
leveraging the underlying fluid dynamics at the considered design stage seemed to be a valid 
strategy per se, and it could effectively simplify some experimental steps including negative 
controls. For instance, with reference to Figure 1b, when the pores are not covered by cells 
(and by assuming l on the order of the said characteristic length), the inflow should exit 
almost completely through the pores (i.e., the flow reaching the external discharge should be 
negligible). Conversely, in correspondence of a perfect cell covering, the liquid volume 
outside the porous segment should remain unperturbed and the whole inflow should reach the 
external discharge. 
In order to estimate the aforementioned characteristic length, we introduced a mathematical 
model. We deliberately aimed at obtaining explicit analytical expressions in order to foster 
model-based chip design. With reference to the schematic in Figures 2d-e, we selected Q and 
p as problem unknowns, and we assumed pext = 0, being the pressure defined up to a constant 
for the considered incompressible-fluid flow.
[23]
 Considering any two of the subsequent 
sections indexed by k in Figures 2e, mass conservation implied Qk+1/2 - Qk-1/2 = -np qk (since q 
was meant to describe the flow rate through a single pore). For ease of model derivation, we 
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assumed the pitch h to be small compared to the sought characteristic length (working 
assumption), and we consistently considered the unknowns as (well-behave) continuous 
functions of the axial space coordinate only (we were looking for a stationary solution). Based 
on this approximation, the aforementioned mass balance could be locally approximated by 
hQ’ = -np q. Moreover, we assumed Equation 1 to describe the momentum balance (formally 
the same as for Poiseuille), yet the pressure gradient was allowed to vary (different from 
Poiseuille). Finally, we assumed a given flow rate Q0 at the tube inlet, in view of the targeted 
experimental conditions. Representing the axial coordinate by x, with x =0 and x = L 
respectively denoting the inlet and the outlet section of the porous tube, we thus considered 







𝑄(𝑥 = 0) = 𝑄0
,         (3) 





𝑄(𝑥 = 0) = 𝑄0















+ 3),  (4) 
where λ immediately provides an intrinsic physical length scale for the considered trends. 
Recalling the relevant parameter values introduced so far (i.e., ϕp = 1 µm, h = 2.5 µm, np = 8, 
ϕt = 9.5 µm and th = 1 µm), one gets λ = 63.6 µm. 
To close and solve the differential problem stated in Equation 4 we considered two 
illustrative cases, both associated with outlet boundary conditions of practical interest for the 











,              with    ?̂? ≡
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   (and  ?̂? ≡
𝐿
𝜆
).   (5) 
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For the second case we assumed Q(x = L) = ωQ0, where ω denotes a (chosen) control 











.     (6) 
The explicit solution provided by Equation 5 corresponds to the experimental conditions 
actually considered in our study, since both the external discharge fluid domain and that one 
outside the porous tube (cf. Figure 1b) were kept at the atmospheric pressure during our tests. 
The explicit solution provided by Equation 6 corresponds to complementary experimental 
conditions that extend those considered in the current study. 
We assessed the obtained continuous solution (with respect to the discrete spillage problem) 
through numerical simulations (Figure 2f-h): details of the numerical simulations are reported 
as Supporting Information. 
Based on the considered results, the analytical solution suitably predicted the relevant 
pressure and flow rate trends, for both outlet conditions. Therefore, we finalized the chip 
design by choosing l =400 µm, since this was also consistent with the previously adopted 
value of H. For completeness, let us remark that we experimentally verified the predicted flow 
behavior; for instance, we fully confirmed that no detectable flow reached the external 
discharge domain when performing negative control experiments. 
Let us remark that, through the developed model, we identified an intrinsic physical length 
scale (λ), and we obtained analytical expressions (primarily the λ expression in Equation 4) 
that can be effectively used to optimize chip design. We know that model accuracy would be 
enhanced for ℎ ≪ 𝜆, whereas it could be spoiled when ϕp is too large compared to ϕt (while 
the sensitivity to the relative magnitude between h and ϕp is less straightforward). 
Nonetheless, the model could be effectively used to further explore and optimize the design 
workspace, since the obtained analytical expressions are physically-based and 
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computationally inexpensive. As example, we could investigate additional values for ϕp, h and 
th. The chosen value of ϕp, for instance, was simultaneously large enough to allow for relevant 
drug molecules to potentially exit the tube and small enough for the pores to be suitably 
covered by the considered cells. Smaller pore diameters, leading in particular to finer pore 
patterns, could be of interest as well. Moreover, the proposed model could be extended so as 
to also consider different cross-sectional shapes for the pores, even if it could be more 
challenging to accurately model β (besides α) for non-circular cross-sections. To conclude, we 
introduced a model-based design approach that can be used to evolve and refine chip design 
beyond the current study and results. 
After fabricating the microfluidic system based on the aforementioned model, we proceeded 
to cultivate bEnd.3 endothelial cells around the porous microcapillaries in order to develop 
the in vitro biohybrid BBB and to test its transendothelial electrical resistance (TEER) and its 
permeability to dextran under dynamic conditions. bEnd.3 cell monolayer represents a 
convenient and widely exploited BBB model, especially for testing the paracellular route of 
transport (for more details please refer to Supplementary Information). 
In the left image of Figure 3a, we report the confocal laser scanning microscopy (CLSM) 3D 
rendering of bEnd.3 cells stained with TRITC-phalloidin (f-actin in red). From the 3D 
imaging, it is possible to appreciate as the bEnd.3 cells are able to efficiently cover the tubular 
structures after 3 days of culture. In the right image of Figure 3a, the high magnification 
SEM imaging of the biohybrid system is reported: this representative scan qualitatively 
reveals the almost complete covering of the pores by the endothelial cells. 
The proposed biohybrid system is envisaged to perform, in future experiments, high-
throughput investigations on the BBB crossing efficiency of different anti-tumoral drugs 
(either plain or associated to nanocarriers). For this reason, we verified the possibility to 
obtain co-culture of human glioblastoma cancer cells on the scaffolds. CLSM of the co-
culture, where plasma membranes of bEnd.3 and of U-87 cells are respectively stained in red 
     
10 
 
and in green and corresponding SEM scan are reported in Figure 3b. U-87 cells resulted able 
to grow on the biohybrid BBB model and can be morphologically identified because of their 
round shape (black arrows in the SEM image). 
The efficient maturation of the tight junctions was verified with an immunofluorescence 
staining against zonula occludens-1 (ZO-1), which reveals a high expression of this marker 
(ZO-1 in green, f-actin in red and nuclei in blue, Figure 3c). The 3D localization of the nuclei 
is reported in Supporting Information (Video S1) and reveals as bEnd.3 cells are positioned 
all around the microcapillaries. 
The quantitative evaluation of the porous area (%) of the microcapillaries without cells and 
after the cell culture or co-culture was performed by analyzing low magnification SEM 
images (Supplementary Information, Figure S5), and the obtained results are reported in 
Figure 3d. The percentage of porous area projection in the microcapillaries without cells 
corresponds to 8.3 ± 0.9 %, and it is significantly higher with respect to that found after 
bEnd.3 (0.52 ± 0.5 %) or bEnd.3/U-87 co-culture (0.54 ± 0.4 %). 
The investigation of dextran diffusion through microcapillaries was carried out both on the 
microfluidic chip without cells and on the biohybrid system with bEnd.3 cells by pumping 
from the inlet a 40 µg ml
-1
 of fluorescent dextran in phenol red-free cell culture medium at 
50 µl h
-1
. Considering that the microfluidic chip is constituted by 50 microcapillaries arranged 
in parallel, the flow in each microcapillary is 1 µl h
-1
 (corresponding to an average speed of 
3.5 mm s
-1
 for a tube diameter of 10 µm), a value comparable to that one of cerebral 
microcapillaries.
[20,21]
 The concentration of the fluorescent dextran was monitored during time 
lapse fluorescence imaging in two regions of interest (ROI) of the extratubular area (ROI1 
and ROI2, respectively located near and far from the porous segment and indicated with blue 
and red colors in Figures 3e-g). Different time points of the fluorescence time lapse imaging 
(recorded at time t = 0, 25, 50 and 75 s) are shown in Figure 3e for the microfluidic system 
without (upper images) and with the cultured cells (lower images). The dextran concentrations 
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over the time in ROI1 and ROI2 are derived from the average fluorescence intensity through a 
calibration curve (Figure S6a) and are reported in Figure 3f for the microcapillaries without 
cells and in Figure 3g for the microcapillaries covered by bEnd.3 cells. 
The concentration of the dextran in the extratubular medium (0.49 ± 0.11 µg ml
-1
 for ROI1 
and 0.32 ± 0.12 µg ml
-1
 for ROI2; t = 75 s) in case of cultured cells is remarkably lower with 
respect to the case of plain porous microcapillaries (2.41 ± 0.58 µg ml
-1
 for ROI1 and 
1.33 ± 0.23 µg ml
-1
 for ROI2; t = 75 s), thus confirming as bEnd.3 cells successfully 
developed a 3D biological barrier around the microcapillaries. The average fluorescence 
intensity of ROI1 is higher with respect to that of ROI2 in both the experimental conditions, 
thus indicating that the fluorescent dextran is permeating from the porous segment and then 
diffusing in the surrounding areas. 
Spectrofluorimetric analyses of the dextran concentration after 4 minutes of experiment in the 
extratubular medium (1.27 ± 0.03 µg ml
-1
 for microcapillaries without cells and 0.28 ± 0.05 
µg ml
-1
 for the biohybrid system) and in the outflow reservoir (0.02 ± 0.01 µg ml
-1
 for 
microcapillaries without cells, and 0.77 ± 0.01 µg ml
-1
 for the biohybrid system) further 
showed the functional efficacy of the biological barrier. Indeed, in the case of the experiment 
without cells, the dextran was found only in the extratubular compartment, while, in the case 
of the biohybrid system, almost all of the dextran was transported through the microcapillaries 
to the outflow reservoir. This result experimentally corroborates the predictivity of our 
analytical model. The dextran concentration in the latter analyses has been derived from the 
calibration curve reported in Figure S6b. 
The bEnd.3 cell covering the microtubular vessels not only induced a remarkably decrease of 
dextran permeability, yet also the TEER significantly increased (75 ± 2 Ω cm2) with respect to 
the microfluidic system without cells (15 ± 5 Ω cm2). These values are comparable with those 
observed on bEnd.3 monolayer-based 2D BBB models, which typically are in the range of 30-
140 Ω cm2.[25–27] Models characterized by similar values of TEER, despite still significantly 
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lower than those in vivo,
[28]
 are successfully adopted for the investigation of 
drug / nanoparticle transport across the BBB.
[25,27]
 Notwithstanding, future experiments can be 
devoted to increase the TEER and to decrease the dextran permeability, for example by co-
culturing endothelial-like cells with astrocytes,
[29]
 treating bEnd.3 cells with astrocyte 
conditioned-medium
[30]
 or with specific molecules (e.g., hydrocortisone
[31]




The TEER of the bEnd.3 monolayer remains stable after 5 days of culture (71 ± 10 Ω cm2), 
thus indicating preserved cell viability and functionality of the BBB model. This is 
qualitatively confirmed by confocal imaging: a representative acquisition is reported in 
Supplementary Information (Figure S7), and shows as the bEnd.3 cells are still viable and 
completely interfaced to the microcapillaries after 5 days of culture. 
The proposed biomimetic dynamic 3D system, characterized by microcapillary diameter size 
and fluid flows similar to the in vivo physiological situations, represents a potential 
improvement of other models already well-established in the literature, since it will allow to 
reliably reproduce the physiological environment and to accurately estimate the amount of 
drugs /  nanomaterial-associated compounds delivered through a modular length of the 
system. Moreover, the cell behavior drastically change from 2D to 3D in vitro models, the 
latter ones allowing more physiologically relevant information and predictive data to be 
obtained.
[34] 
Our work can be considered a further step in this direction, by providing a new 
reliable platform where the role of different molecules on the development of the 3D 
functional barrier can be investigated. 
Concluding, we modeled, fabricated and characterized for the first time a prototype of 3D 1:1 
scale biohybrid BBB. The high resolution and reproducibility of the TPL technique will allow 
to finely tune different parameters (e.g., pore and microcapillary diameter, pore density, 
porous segment length, etc.) in order to refine our system and adapt it to model blood vessels 
of different sizes and morphologies. Future studies will be dedicated to investigate the 
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permeability of different  compounds / anticancer agents, even in their free form or associated 
with nanomaterials, through the BBB model, and possibly ad hoc modified or functionalized, 
respectively, in order to efficiently reach the barrier. Moreover, owing to the reverse 
engineering approach, the architecture of brain microvasculature in physiologic healthy and 
non-healthy conditions (for example, in case of brain tumors) can be reconstructed through 
3D CLSM and then reproduced through TPL. These future investigations will allow to 
faithfully mimic in vitro the 3D neurovasculature of different pathological conditions, and to 
perform high-throughput studies in which a variety of drug treatments / therapeutic 
approaches may be tested. 
 
Supporting Information 
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Figure 1. Bioinspired microfluidic system design and microfabrication. a) Schematic of the 
porous tube (mimicking a microcapillary) that simultaneously scaffolds the cells and allows 
for species transport towards the external environment. b) Schematic (top view) of the 
microfluidic chip devised to operate multiple porous tubes in parallel. c) Scheme depicting the 
two-photon lithography fabrication of the microfluidic system with porous tubular-shaped 
microcapillaries. d) Design of the microfluidic system consisting of the microcapillaries 
arranged in parallel and connected to the inflow and the outflow reservoirs. e) High 
magnification of the designed porous microcapillaries. Representative scanning electron 
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microscopy images f) of the obtained microfluidic chip, g) of the tubes, and h) of the pores, 
highlighting the high reproducibility and resolution of the fabrication technique. 
 
  






Figure 2. Modeling of the microfluidic system. a) Intensity plot of the fluid speed 
numerically computed on a simplified 2D geometry (half domain, by symmetry). b) Detail 
showing the struts supporting the junctions, and the considered cut-sections (δ = 0.01 µm). c) 
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Axial velocity trends on the cut-sections: their uniformity shows that the considered geometry 
permits to operate the microcapillaries in parallel, as desired. d) Schematic of the porous tube 
fluid domain. Both the core and the spillage flow rates are indicated (only some spillages, for 
simplicity), together with relevant geometrical and physical entities. e) Schematic (sagittal 
cut-section) of the tube indicating, in particular, the axial pressure damping due to viscosity: 
after a characteristic length, pressure difference is dissipated so that spillage becomes 
negligible. We estimated such a characteristic length by introducing an analytical model, and 
we exploited that estimate to also set the length of the porous tube. f) Schematic of the fluid 
domain (relevant portion, by symmetry) used in the 3D numerical simulations carried out to 
assess the accuracy of the analytical model. g, h) Illustrative results showing that the 
analytical solution approximates the numerical one accurately enough for our purposes; both 
the solutions reported in Equation 5 and Equation 6 are considered, respectively in g) and 
h), for completeness. Explicitly accounting for relevant physical entities, the analytical 
solution provides a useful tool to evolve and optimize chip design. 
 
  






Figure 3. Dynamic 3D real scale bio-hybrid blood-brain barrier model. a) In the left image, 
the 3D rendering of confocal laser scanning microscopy (CLSM) showing bEnd.3 cells (f-
actin in red) cultured covering the porous tubes of the microfluidic system; the right image 
shows a high magnification SEM image. b) Co-culture of endothelial-like bEnd.3 and human 
glioblastoma U-87 cells on the porous tubes of the microfluidic system; in the left image, the 
CLSM of bEnd.3 and U-87 cell membranes (shown in red and in green, respectively) and, in 
the right image, SEM image with black arrows indicating U-87 cells. c) Immunofluorescence 
staining against zonula occludens-1 (ZO-1), revealing a high expression of this marker (ZO-1 
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in green, f-actin in red and nuclei in blue). d) Quantitative evaluation of the porous area (%) 
of the microcapillaries without cells and after the culture / co-culture. e) Fluorescence time-
lapse images of the fluorescent dextran pumped in the microfluidic system without cells 
(images on top) and on the bio-hybrid system with bEnd.3 cells (images on bottom) and 
acquired at time t = 0, 25, 50 and 75 s. The extratubular concentration of the fluorescent 
dextran was monitored during time-lapse fluorescence imaging in two region of interest 
(ROI1 and ROI2). The extratubular dextran concentrations over time in ROI1 and ROI2 for 
the microcapillaries without cells and covered by bEnd.3 cells are reported in f) and g), 
respectively. 
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A 3D, real-scale, and biomimetic model of the blood-brain barrier (BBB) is proposed. 
Taking advantage of the two-photon lithography technique, an in vitro biohybrid dynamic 
BBB model has been developed and fully characterized, aiming at obtaining a realistic tool 
for the testing of drug targeting and delivery at the level of the central nervous system. 
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